Therapeutic Effects of a New Long-Acting Growth Factor Cocktail (Cellcurex™) Injected Using a Microneedle on the Scalp in Patients With Androgenetic Alopecia: A Split Study
January 2021
in “
Global Dermatology
”
New to Microneedling? There is a guide in the encyclopedia. Read the guide → Studysummary This study involved selecting patients with specific types of alopecia for treatment but does not report clinical outcomes.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study assessed the effects of a new long-acting growth factor cocktail, Cellcurex™, delivered via microneedling on the scalps of 22 patients with androgenetic alopecia over 12 weeks. The right side of the scalp received the treatment, resulting in a significant increase in hair density and diameter, while the left side, treated with saline, showed no significant changes. Despite the positive outcomes in hair regrowth and thickness, the procedure caused pain and minimal bleeding, highlighting the need for further research to evaluate long-term efficacy and reduce adverse effects.
